Eight Months of Serological Follow-Up of Anti-SARS-CoV-2 Antibodies in France: A Study among an Adult Population

被引:0
|
作者
Decarreaux, Dorine [1 ,2 ,3 ]
Sevila, Julie [1 ]
Masse, Shirley [1 ]
Capai, Lisandru [1 ]
Fourie, Toscane [3 ]
Villarroel, Paola Mariela Saba [3 ]
Amroun, Abdennour [3 ]
Nurtop, Elif [3 ]
Vareille, Matthieu [1 ]
Blanchon, Thierry [2 ]
de Lamballerie, Xavier [3 ]
Charrel, Remi [3 ]
Falchi, Alessandra [1 ]
机构
[1] Univ Corse Pascal Paoli, Lab Virol, UR7310 Bioscope, F-20250 Corte, France
[2] Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, INSERM, IPLESP, F-75012 Paris, France
[3] Aix Marseille Univ, Unite Virus Emergents, IHU Mediterranee Infect, INSERM U1207,IRD 190, F-13005 Marseille, France
关键词
COVID-19; seroconversion; long-lasting immunity; antibodies; vaccination; INFECTION; COVID-19;
D O I
10.3390/ijerph192215257
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: Uncertainties remain regarding the nature and durability of the humoral immune response to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Aim: This study investigated immunoglobulin G response and neutralizing activity to evaluate the mean antibody concentrations and response duration induced by each vaccination regimen in a French adult population. Methods: A study including blood sampling and questionnaires was carried out from November 2020 to July 2021 with three separate follow-up phases. Spike proteins and neutralizing antibodies were quantified using ELISA and a virus-neutralization test. Results: Overall, 295 participants were included. Seroprevalences were 11.5% (n = 34), 10.5% (n = 31), and 68.1% (n = 201) in phases 1, 2, and 3, respectively. Importantly, 5.8% (n = 17) of participants lost their natural antibodies. Antibody response of participants with only a prior infection was 88.2 BAU/mL, significantly lower than those vaccinated, which was 1909.3 BAU/mL (p = 0.04). Moreover, the antibody response of vaccinated participants with a prior infection was higher (3593.8 BAU/mL) than those vaccinated without prior infection (3402.9 BAU/mL) (p = 0.78). Vaccinated participants with or without prior infection had a higher seroneutralization rate (91.0%) than those unvaccinated with prior infection (65.0%). Conclusion: These results demonstrated that single infection does not confer effective protection against SARS-CoV-2.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study
    Tancredi, Stefano
    Chiolero, Arnaud
    Wagner, Cornelia
    Haller, Moa Lina
    Chocano-Bedoya, Patricia
    Ortega, Natalia
    Rodondi, Nicolas
    Kaufmann, Laurent
    Lorthe, Elsa
    Baysson, Helene
    Stringhini, Silvia
    Michel, Gisela
    Ludi, Chantal
    Harju, Erika
    Frank, Irene
    Imboden, Medea
    Witzig, Melissa
    Keidel, Dirk
    Probst-Hensch, Nicole
    Amati, Rebecca
    Albanese, Emiliano
    Corna, Laurie
    Crivelli, Luca
    Vincentini, Julia
    Nussle, Semira Gonseth
    Bochud, Murielle
    D'Acremont, Valerie
    Kohler, Philipp
    Kahlert, Christian R.
    Cusini, Alexia
    Frei, Anja
    Puhan, Milo A.
    Geigges, Marco
    Kaufmann, Marco
    Fehr, Jan
    Cullati, Stephane
    INFECTION, 2023, 51 (05) : 1453 - 1465
  • [42] Seroprevalence of anti-SARS-CoV-2 antibodies in a population living in Bomassa village, Republic of Congo
    Ingoba, Line Lobaloba
    Djontu, Jean Claude
    Mapanguy, Claujens Chastel Mfoutou
    Mouzinga, Freisnel
    Kietela, Steve Diafouka
    Vouvoungui, Christevy
    Kuisma, Eeva
    Nguimbi, Etienne
    Ntoumi, Francine
    IJID REGIONS, 2022, 2 : 130 - 136
  • [43] Anti-SARS-CoV-2 antibodies among indigenous populations of the Brazilian Amazon: a cross-sectional study
    Cordeiro Lima, Carlos Neandro
    Abreu, Isabella Nogueira
    Sacuena Rodrigues, Eliene Putira
    Freitas, Vanessa de Oliveira
    Sarmento Botelho, Bruno Jose
    Souza, Sandra Lima
    Cayres-Vallinoto, Izaura
    Guerreiro, Joao Farias
    Ishak, Ricardo
    Vallinoto, Antonio C. R.
    BMJ OPEN, 2022, 12 (02):
  • [44] Anti-SARS-CoV-2 antibodies among vaccinated healthcare workers: Repeated cross-sectional study
    Mishra, Sanjeeb Kumar
    Pradhan, Subrat Kumar
    Pati, Sanghamitra
    Panda, Bimal Krushna
    Bhattacharya, Debdutta
    Sahu, Sumanta Kumar
    Kshatri, Jaya Singh
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (05) : 1883 - 1889
  • [45] Positive anti-SARS-CoV-2 rapid serological test results among asymptomatic blood donors
    Arabkhazaeli, Ali
    Maghsudlu, Mahtab
    Mohammadi, Saeed
    Eshghi, Peyman
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2022, 29 (01) : 24 - 30
  • [46] Correlation of ELISA method with three other automated serological tests for the detection of anti-SARS-CoV-2 antibodies
    Nguyen, Nguyen N.
    Mutnal, Manohar B.
    Gomez, Richard R.
    Pham, Huy N.
    Nguyen, Lam T.
    Koss, William
    Rao, Arundhati
    Arroliga, Alejandro C.
    Wang, Liping
    Wang, Dapeng
    Hua, Yinan
    Powell, Priscilla R.
    Chen, Li
    McCormack, Colin C.
    Linz, Walter J.
    Mohammad, Amin A.
    PLOS ONE, 2020, 15 (10):
  • [47] Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients
    Rostamzadeh, Davood
    Mortezagholi, Sahar
    Alinejad, Maedeh
    Jooya, Seyed Reza
    Eskandarian, Maryam
    Metvaei, Alireza
    Vafaei, Sedigheh
    Aboulghasemi, Hasan
    Younesi, Vahid
    Shabani, Mahdi
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2021, 210 (5-6) : 283 - 289
  • [48] Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients
    Davood Rostamzadeh
    Sahar Mortezagholi
    Maedeh Alinejad
    Seyed Reza Jooya
    Maryam Eskandarian
    Alireza Metvaei
    Sedigheh Vafaei
    Hasan Aboulghasemi
    Vahid Younesi
    Mahdi Shabani
    Medical Microbiology and Immunology, 2021, 210 : 283 - 289
  • [49] Anti-SARS-CoV-2 antibody kinetics up to 6 months of follow-up: Result from a nation-wide population-based, age stratified sero-epidemiological prospective cohort study in India
    Misra, Puneet
    Singh, Arvind Kumar
    Mishra, Baijayantimala
    Behera, Bijayini
    Patro, Binod Kumar
    Medigeshi, Guruprasad R.
    Joshi, Hari Shanker
    Ahmad, Mohammad
    Chaturvedi, Pradeep Kumar
    Chinnakali, Palanivel
    Haldar, Partha
    Bairwa, Mohan
    Kharya, Pradeep
    Dhodapkar, Rahul
    Rath, Ramashankar
    Guleria, Randeep
    Rai, Sanjay Kumar
    Kar, Sitanshu Sekhar
    Kant, Shashi
    Sarkar, Sonali
    Baidya, Subrata
    Meena, Suneeta
    Mandal, Suprakash
    Kishore, Surekha
    Majumder, Tapan
    Hada, Vivek
    PLOS ONE, 2023, 18 (12):
  • [50] Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina
    Halili, Rrezart
    Bunjaku, Jeta
    Gashi, Bujar
    Hoxha, Teuta
    Kamberi, Agron
    Hoti, Nexhmedin
    Agahi, Riaz
    Basha, Vlora
    Berisha, Visar
    Hoxha, Ilir
    BMC INFECTIOUS DISEASES, 2022, 22 (01)